Seevix Material Sciences Ltd.

What Seevix Material Sciences Ltd. does

Seevix Material Sciences Ltd. is a privately held Israeli biotech company headquartered in Jerusalem that manufactures SVX™, a proprietary synthetic spider silk-inspired biopolymer. The company is co-founded and led by Dr. Shlomzion Shen (CEO) and Dr. Shmulik Ittah, with a multidisciplinary R&D team spanning biology, chemistry, and engineering. SVX™ is produced via a proprietary process that replicates the molecular structure of natural spider silk, yielding material properties including 6× the tensile strength of high-tensile steel at one-fifth the weight, elasticity up to 35%, and thermal resilience to +230°C, in a manufacturing process that is animal-free, bio-degradable, and petroleum-free.

Seevix commercializes SVX™ through two primary product lines: SpheroSeev, a 3D cell culture matrix that supports spheroid formation for hepatotoxicity testing, ADME-Tox, drug discovery, stem cell and cancer research, tissue engineering, and 3D bioprinting; and HydroSeev, a hydrogel enrichment system for organoid and tumoroid applications. Named customers and research collaborators include Weizmann Institute of Science, Tel-Aviv University, Sheba Medical Center, and Hebrew University. Products are sold as catalog vials (with shelf life up to 3 years unopened, 1 year after opening) via the company website and regional distributors in the USA and Europe.

Beyond life sciences, Seevix positions SVX™ for cosmetics ingredients (anti-aging skin and hair care) and composite materials (textiles, automotive, sports and outdoors, packaging, construction, aerospace), generating revenue through one-time product sales and SVX™ technology licensing. Its GTM is product-led, supported by a Knowledge Center of peer-reviewed publications, application notes, working protocols, and spec sheets, and amplified through LinkedIn and X/Twitter.

Name

Seevix Material Sciences Ltd.

Legal name

Seevix Material Sciences Ltd.

Website

https://seevix.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Seevix Material Sciences is a Jerusalem-based biotech that manufactures SVX™, a proprietary synthetic spider silk-inspired biopolymer, and sells it as SpheroSeev and HydroSeev 3D cell culture products to academic, medical, and pharmaceutical researchers worldwide.

Ownership category

akta.pro rank

Product category

Biotechnology Materials

NAICS

Artificial and Synthetic Fibers and Filaments Manufacturing (32522), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)

SIC

Broadwoven Fabric Mills, Man Made Fiber & Silk (2221)

akta.pro primary industry

Man-Made Fiber Manufacturing (Polyester/Nylon/Acrylic/Viscose) (IMAOAAAB)

akta.pro secondary industry

Industrial & Technical Yarn Manufacturing (High-Tenacity/Aramid/Carbon/Glass) (IMAOAAAG)

Keywords

• Synthetic spider silk
• 3D cell culture
• Biopolymer materials
• Composite materials
• Cosmetic ingredients

Headquarters

HQ city

Jerusalem

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. 3D Cell Culture Product Sales: Seevix generates revenue through the sale of 3D cell culture products (SpheroSeev and HydroSeev) as catalog products. Products are sold as vials of biopolymer dispersed in aqueous solution, with stable shelf life of up to 3 years unopened.
2. SVX™ Technology Licensing:

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Seevix manufactures SVX™, a synthetic spider silk-inspired biopolymer material with exceptional mechanical properties (6X stronger than high tensile steel, 1/5 the weight, heat resistant up to +230°C). The company commercializes SVX™ through its catalog 3D cell culture products SpheroSeev and HydroSeev for life sciences research, and through SVX™ licensing for cosmetics formulations and composite materials across textiles, automotive, aerospace, and other industries.

Product overview

Seevix Material Sciences Ltd. manufactures SVX™, a synthetic spider silk-inspired biopolymer material, as its core technology platform. The company commercializes this material through two main product lines: SpheroSeev and HydroSeev, which are specialized formulations for 3D cell culture applications. Additionally, SVX™ is applied in cosmetics formulations and composite materials for various industries including textiles, automotive, sports, packaging, construction, and aerospace.

Differentiator

Problem solved

Functional benefit

Brands

• SpheroSeev: 3D cell culture product for spheroid formation used in hepatotoxicity, ADME-Tox, drug discovery, stem cell research, cancer research, tissue engineering and 3D bioprinting.
• HydroSeev
• SVX

Products and services

• SVX™ Synthetic Spider Silk Biopolymer SVX™ is a synthetic biopolymer material inspired by natural spider silk, offering 6X the strength of high tensile steel at 1/5 the weight, stretches up to 35% without tearing, and remains durable up to +230°C. It is manufactured through a green, animal-free, bio-degradable, and petroleum-free process and is licensed for integration into cosmetics formulations and composite materials across textiles, automotive, sports, packaging, construction, and aerospace.
• SpheroSeev 3D Cell Culture Matrix SpheroSeev is a porous nano/micro fiber 3D cell culture matrix that provides an ECM-like environment for spheroid formation. It is used by academic and pharmaceutical researchers for hepatotoxicity testing, ADME-Tox studies, drug discovery, stem cell research, cancer research, tissue engineering, and 3D bioprinting, supporting spheroid viability for over 41 days.
• HydroSeev Hydrogel Enrichment System HydroSeev is a 3D cell culture product used to enrich hydrogels, providing an ECM-like environment with high porosity for better nutrient and oxygen access in organoid and tumoroid formation, supporting co-culture and stem cell research workflows.

Quantifiable outcome

• SpheroSeev increases hepatocyte spheroid longevity for over 41 days compared to ~20 days without
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Weizmann Institute of SciencecoreStrategic or Co-development PartnerAcademic research collaboration where SpheroSeev and HydroSeev products are used in various research projects including colorectal cancer cell line studies, demonstrating product efficacy in 3D cell culture applications.
• Tel-Aviv UniversitycoreStrategic or Co-development PartnerAcademic partnership for precision nanomedicine research, where SpheroSeev was used to grow ovarian cancer spheroids demonstrating improved viability and cytotoxicity assay sensitivity.
• Sheba Medical CentercoreStrategic or Co-development PartnerRegenerative medicine research collaboration using SpheroSeev for human normal primary spheroid production, showing dramatically increased cell viability.
• Hebrew UniversitycoreStrategic or Co-development PartnerAcademic research partnership for glioblastoma cell culture studies using SpheroSeev, demonstrating the product's ability to maintain stemness of cells and form stable tumor spheres.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• BICO Group (Cellink): Swedish bioconvergence company offering bioprinters, bioinks, and 3D cell culture products; overlaps with Seevix in tissue engineering, 3D bioprinting, and 3D cell culture workflows.
• Corning Life Sciences: Large incumbent supplying Matrigel and other 3D cell culture matrices; competes in the same 3D cell culture reagent category as SpheroSeev/HydroSeev with a much broader catalog and distribution.

Direct peers

• Spiber Inc. Japanese biotech that developed Brewed Protein™, a synthetic spider-silk-like structural protein, addressing apparel, automotive, and cosmetics applications. Closest comparable in core technology platform and multi-vertical go-to-market approach.
• QGel SA: Swiss/US company offering synthetic, fully defined 3D cell culture hydrogels for drug discovery and tumoroid applications; competes head-to-head with HydroSeev in the 3D matrix market.
• AMSilk: German producer of silk-based biopolymers for textiles, medical devices, and cosmetics; directly comparable as a competing recombinant silk platform targeting overlapping end markets.
• Bolt Threads: US-based protein materials company producing synthetic spider silk and engineered fibers for apparel and cosmetics, with a comparable licensing-and-brand-collaboration strategy.
• Modern Meadow: US biotech using protein engineering and biofabrication to produce sustainable materials (including collagen and leather alternatives); overlapping technology base and sustainability-led value proposition.
• Kraig Biocraft Laboratories: US-listed company developing recombinant spider silk via transgenic silkworms for textile and defense applications; competes in the same spider silk performance fiber category.

Emerging players

• Gelomics: Australia-based supplier of tunable, synthetic peptide hydrogels for 3D cell culture; comparable as an emerging alternative to animal-derived matrices targeting similar research customers.
• VitroLabs: US startup biofabricating leather and other materials via cell culture; overlaps thematically with Seevix's composite materials and sustainability-driven bio-based manufacturing approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/seevixms
• LinkedInlinkedin.com/company/seevix-material-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seevix Material Sciences Ltd.